Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Effect of Rice Fortification With Iron on Anemia Among Children
This study has been completed.
Sponsored by: Federal University of Rio de Janeiro
Information provided by: Federal University of Rio de Janeiro
ClinicalTrials.gov Identifier: NCT00727545
  Purpose

This was a double-blind community-based trial, placebo controlled. During 16 weeks, children in the intervention group (GI, n=180) received iron fortified rice, and children in the control group (GC, n=174) received rice with placebo. Anemia was considered present when hemoglobin < 11.0g/dL. Comparison of mean variation on hemoglobin between groups was accessed by using Student's t-test. Hemoglobin concentration improved in both groups, with mean increase of 0.42 g/dL in GI (11.28±1.23 g/dL to 11.75±1.16 g/dL, p < 0.001), and 0.49 g/dL in GC (11.06±1.13 g/dL to 11.51±1.16 g/dL, p < 0.001). Anemia decreased (p < 0.01) in both groups (37.8% to 23.3% in GI and 45.4% to 33.3% in GC), with no differences between them. Hemoglobin increase was significantly higher in children who received total amount of iron ≥ 53.76 mg from fortified rice, compared to those who received less than this cut-off value (0.94 g/dl vs 0.39 g/dl p=0.03). The results suggest that this type of intervention can be useful in anemia control if fortified food intake is adequate.


Condition Intervention Phase
Iron Deficiency Anemia
Other: iron bisglycine chelate
Other: placebo
Phase II
Phase III

MedlinePlus related topics: Anemia
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Non-Randomized, Double Blind (Subject, Caregiver, Investigator), Placebo Control, Parallel Assignment, Efficacy Study
Official Title: Effect of Weekly Rice Fortification With Iron on Frequency of Anemia and Hemoglobin Concentration Among Children Attending Public Day Care Centers From Rio de Janeiro

Further study details as provided by Federal University of Rio de Janeiro:

Primary Outcome Measures:
  • Hemoglobin in crease

Enrollment: 385
Study Start Date: March 2006
Study Completion Date: December 2006
Arms Assigned Interventions
1: Experimental Other: iron bisglycine chelate Other: placebo

  Eligibility

Ages Eligible for Study:   12 Months to 60 Months
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • pre-school children attending public day care centers

Exclusion Criteria:

  • sickle cell anemia, purpura
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00727545

Locations
Brazil
Public day care centers
Rio de Janeiro, Brazil
Sponsors and Collaborators
Federal University of Rio de Janeiro
  More Information

Responsible Party: Universidade Federal do Rio de Janeiro ( Ursula Viana Bagni )
Study ID Numbers: UFRJ-1
Study First Received: July 30, 2008
Last Updated: August 4, 2008
ClinicalTrials.gov Identifier: NCT00727545  
Health Authority: Brazil: Ethics Committee

Study placed in the following topic categories:
Metabolic Diseases
Hematologic Diseases
Anemia
Iron Metabolism Disorders
Metabolic disorder
Iron
Anemia, Iron-Deficiency

Additional relevant MeSH terms:
Anemia, Hypochromic

ClinicalTrials.gov processed this record on January 14, 2009